potenti
hormon
action
occur
differ
mechan
includ
inhibit
degrad
enzym
interact
hormon
receptor
lead
stabil
bioactiv
conform
lead
receptor
homoand
heterooligomer
receptor
phosphoryl
dephosphoryl
occur
directli
influenc
signal
transduct
ion
channel
review
potenti
bradykinin
action
differ
system
certain
compound
review
despit
mani
long
year
experiment
research
investig
mechan
potenti
action
remain
fulli
understood
one
contradictori
find
distinct
differ
inhibit
angiotensin
iconvert
enzym
potenti
bradykinin
induc
smooth
muscl
reaction
contradictori
find
hypothes
mechan
literatur
discuss
review
case
compar
result
investig
potenti
action
extend
hypotens
smooth
muscl
reaction
cellular
action
activ
immunocompet
cell
opinion
potenti
bradykinin
action
occur
differ
mechan
depend
system
appli
potenti
factor
use
hormon
action
potenti
differ
factor
interact
receptor
enzymat
degrad
signal
pathway
howev
entir
overal
process
studi
detail
hormon
therapeut
use
hormon
knowledg
potenti
compound
action
mechan
ism
import
type
inform
therapi
improv
exampl
better
determin
proper
dosag
increas
awar
possibl
neg
side
effect
interact
drug
therapeut
use
potenti
compound
also
requir
howev
knowledg
interact
molecular
level
potenti
hormon
action
also
help
uncov
basic
process
signal
transduct
receptor
level
potenti
peptid
enhanc
affin
ligand
enhanc
receptor
densiti
trigger
homodimer
heterodimer
function
membran
protein
enzym
receptor
well
trigger
phosphoryl
dephosphoryl
cytosol
receptor
loop
bradykinin
potenti
peptid
may
directli
activ
gprotein
increas
receptor
densiti
attenu
signal
pathway
evok
anoth
hormon
biolog
activ
compound
alreadi
known
numer
studi
potenti
bradykinin
action
exist
variou
potenti
peptid
distinct
sequenc
sinc
potenti
action
estim
differ
vivo
ex
vivo
cell
base
assay
biochem
test
addit
use
differ
potenti
compound
lot
conflict
result
obtain
lead
intens
differ
opinion
least
forti
year
ago
potenti
action
observ
nonapeptid
bradykinin
bk
inde
histori
bk
isol
character
long
close
relat
use
potenti
factor
rocha
e
silva
cowork
use
snake
venom
trigger
format
bradykinin
plasma
describ
tissu
hormon
function
immedi
isol
chemic
character
synthesi
function
character
certain
snake
venom
describ
bradykinin
potenti
compound
kato
et
al
ferreira
et
al
ondetti
et
al
isol
differ
oligopeptid
bradykinin
potenti
activ
venom
two
snake
agkistrodon
hali
blomhoffii
bothrop
jararaca
includ
bradykinin
potenti
nonapeptid
bpp
trade
name
teprotid
peptid
first
test
potenti
bkinduc
contract
isol
guinea
pig
ileum
gpi
bradykinin
potenti
peptid
also
isol
snake
venom
scorpion
well
venom
spider
tabl
surprisingli
peptid
potenti
activ
also
form
partial
hydrolysi
protein
serum
hemoglobin
milk
wheat
germ
also
degrad
fragment
angiotensin
heptapeptid
found
potenti
bk
action
addit
linear
bk
analogu
partial
sequenc
well
certain
activ
inact
side
chain
back
bone
cyclic
bk
agonist
abl
potenti
bk
action
gpi
contractil
effect
bk
gpi
rat
uteru
rut
could
shown
potenti
thiol
reagent
includ
cystein
also
athioglycerol
cystein
ten
time
potent
bk
induc
relax
contract
wherea
potenti
factor
show
nearli
activ
test
system
find
indic
differ
mechan
involv
special
sourc
bpp
ctype
natriuret
peptid
precursor
snake
venom
gland
snake
brain
bpp
taken
brain
bothrop
jararaca
inhibit
angiotensin
iconvert
enzym
ace
ec
nanomolar
rang
potenti
bk
effect
ex
vivo
vivo
experi
presenc
bpp
within
neuroendocrin
regul
ctype
natriuret
peptid
precursor
express
brain
region
suggest
peptid
belong
endogen
vasoact
compound
hayashi
et
al
assum
ctype
natriuret
peptid
brain
bpp
could
physiolog
interrel
like
fluid
homeostasi
process
inhibit
bradykinin
degrad
first
explan
potenti
effect
measur
potenti
bkinduc
contract
isol
smooth
muscl
organ
potenti
bk
action
also
investig
vivo
model
pharmacolog
test
isol
organ
cellular
level
biochem
method
potenti
bk
action
measur
vivo
hypotens
effect
freeli
move
wistar
rat
isol
organ
guinea
pig
ileum
rat
heart
rabbit
jugular
vein
cerebr
microvasculatur
permeabl
porcin
coronari
arteri
use
vitro
test
initi
experiment
potenti
bradykinin
action
primarili
perform
isol
smooth
muscl
organ
last
decad
potenti
activ
mainli
investig
affin
densiti
receptor
intracellular
mobil
ca
releas
arachidon
acid
inositol
phosphat
nitric
oxid
later
studi
molecular
level
bkevok
action
center
increasingli
cell
cultur
rather
smooth
muscl
studi
primarili
use
chines
hamster
ovari
cell
cho
cell
cotransfect
b
receptor
ace
ace
mutant
neutral
endopeptidas
nep
endotheli
cell
use
constitut
express
b
receptor
ace
hypothes
mani
differ
potenti
mechan
exist
includ
nonreceptormedi
well
receptormedi
reaction
also
reaction
receptor
molecul
fig
one
earliest
plausibl
explan
potenti
action
inhibit
bradykinin
destroy
enzym
like
ace
nep
proteas
certain
physiolog
pathophysiolog
condit
teprotid
consid
exert
hypotens
effect
inhibit
renin
angiotensin
system
sinc
bk
degrad
link
activ
composit
proteolyt
enzym
use
test
system
differ
activ
factor
result
influenc
membran
potenti
increas
ca
influx
extracellular
sourc
also
possibl
reaction
receptormedi
action
includ
intracellular
mobil
ca
increas
format
ip
n
arachidon
acid
prostaglandin
hypothet
possibl
non
bk
receptormedi
stimul
pathway
direct
interact
gprotein
crosstalk
pathway
receptor
also
receptor
molecul
phosphoryl
dephosphoryl
cytosol
loop
receptor
homoor
heterooligomer
human
genom
open
new
hypothet
mechan
thu
orphan
receptor
bradykinin
receptor
gpr
act
target
potenti
factor
enhanc
receptor
affin
physiolog
concentr
interact
potenti
peptid
bk
receptor
suggest
interact
occur
certain
mechan
might
exist
initi
potenti
factor
could
act
similarli
alloster
effector
stabil
activ
receptor
conform
secondli
factor
could
influenc
phosphoryl
dephosphoryl
cytosol
part
receptor
result
desensit
resensit
receptor
third
possibl
mechan
might
influ
tabl
natur
sourc
bradykinin
potenti
peptid
potenti
peptid
differ
sourc
differ
chain
length
amino
acid
sequenc
potenti
activ
test
vivo
cell
cultur
biochem
method
bothrop
jararaca
b
insulari
b
jararacussu
b
neuwiedi
agkistrodon
hali
blomhoffii
hali
palla
piscivoru
echi
multisquamatu
degrad
fragment
angiotensin
bpp
ctype
natriuret
peptid
precursor
snake
brain
insulin
enc
potenti
factor
receptor
oligomer
mainli
homoor
heterodimer
influenc
homodimer
dimer
bk
antagonist
signal
recent
postul
chan
et
al
abdalla
et
al
found
activ
high
affin
angiotensin
receptor
bkrb
abl
form
heterodimer
complex
smooth
muscl
cell
import
heterodimer
evok
signal
enhanc
possibl
use
explan
potenti
effect
inhibit
angiotensin
iconvert
enzym
angiotensin
iconvert
enzym
cleav
dipeptid
cterminu
angiotensin
bradykinin
result
one
hand
format
highli
hypertens
hormon
angiotensin
ii
hand
inactiv
hypotens
bk
enzym
extens
studi
import
function
blood
pressur
regul
ace
membranebound
ectoenzym
vascular
endotheli
cell
also
express
sever
cell
type
includ
male
germin
cell
somat
tissu
ace
glycoprotein
singl
polypeptid
chain
kda
germin
cell
ace
synthes
lower
molecular
mass
form
kda
display
catalyt
properti
angiotensin
similar
somat
ace
somat
ace
primarili
involv
enzymat
inactiv
bk
two
catalyt
center
slightli
differ
structur
requir
substrat
inhibitor
optim
catalyt
condit
cotton
et
al
recent
describ
use
domainspecif
substrat
inhibitor
affin
differ
nand
ctermin
catalyt
domain
order
magnitud
natesh
et
al
determin
crystal
structur
human
testicular
ace
complex
one
wide
use
inhibitor
lisinopril
resolut
testi
ace
ident
ctermin
half
somat
ace
except
uniqu
sequenc
constitut
amino
terminu
thu
structur
provid
opportun
design
ctermin
catalyt
domainselect
ace
inhibitor
may
exhibit
new
pharmacolog
profil
addit
isoform
ace
recent
describ
homologu
vasoact
peptidas
ace
similarli
ace
integr
membran
zinc
metallopeptidas
less
wide
distribut
ace
bodi
express
highest
concentr
heart
kidney
testi
also
differ
ace
substrat
specif
function
exclus
carboxypeptidas
rather
peptidyl
dipeptidas
seem
unlik
ace
receptor
sar
coronaviru
therefor
like
import
therapeut
target
potenti
exclus
reduc
inhibit
ace
yet
even
onset
search
molecular
mechan
bk
potenti
certain
find
contradictori
inhibit
ace
variou
peptid
nonpeptid
compound
correl
well
potenti
activ
furthermor
maximum
bkinduc
submaxim
contract
guinea
pig
ileum
enhanc
potenti
compound
also
action
evok
enzymat
stabl
bk
agonist
potenti
test
system
addit
contradictori
result
also
found
affin
label
bpp
analogu
abl
inhibit
bpp
induc
potenti
bk
action
gpi
bk
action
alon
influenc
expect
inhibit
ace
label
peptid
lead
perman
potenti
bk
action
interact
indic
repeat
exposur
porcin
coronari
arteri
bk
led
receptor
desensit
addit
potenti
compound
quinaprilat
angiotensin
fulli
restor
relax
effect
point
bk
alon
longer
abl
induc
relax
molecular
level
coimmunoprecipit
ace
b
receptor
anti
receptor
antibodi
clearli
indic
interact
partner
cell
membran
distinct
differ
potenti
bkinduc
contract
isol
guinea
pig
ileum
inhibit
isol
angiotensin
iconvert
enzym
bpp
intens
investig
deriv
natur
sequenc
bradykinin
potenti
peptid
numer
analogu
synthes
base
synthet
analogu
well
structur
activ
relationship
conform
shape
studi
comparison
smooth
muscl
contract
ace
inhibit
show
distinct
differ
activ
conform
analys
differ
spectroscop
method
e
circular
dichroism
electronspinreson
fluoresc
indic
turn
shape
allow
degre
differenti
conform
favor
potenti
gpi
contract
inhibit
ace
inhibitori
potenti
activ
analogu
select
recent
origin
public
list
tabl
shown
tabl
distinct
differ
exist
potenti
bkinduc
contract
guinea
pig
ileum
inhibit
isol
ace
quantifi
differ
quotient
calcul
activ
analogu
bpp
quotient
account
found
distinct
differ
nonapeptid
analogu
partial
sequenc
label
azidosalicyl
acid
asa
quotient
reach
tabl
indic
strongli
differ
structur
requir
biolog
activ
inconsist
exclus
reduct
potenti
action
inhibit
ace
conclus
might
drawn
despit
differ
sourc
isol
organ
ace
sinc
bk
receptor
speci
depend
human
bkrb
share
sequenc
homolog
guinea
pig
wherea
structur
requir
substrat
inhibitor
ace
seem
less
speci
independ
thu
despit
exist
speci
specif
ace
nine
differ
mammalian
speci
could
test
substrat
inhibit
captopril
interestingli
potenti
activ
quit
less
influenc
amino
acid
replac
modif
lead
peptid
bpp
inhibit
ace
quantit
structur
activ
relationship
qsar
studi
activ
taken
literatur
becam
difficult
use
differ
biolog
test
appli
variou
author
recent
approach
undertaken
analyz
predict
biolog
activ
use
qualit
structur
activ
relationship
studi
cushman
et
al
creat
model
activ
center
bradykinin
degrad
proteolyt
enzym
ace
base
model
inhibitor
enzym
use
drug
treatment
differ
form
hypertens
heart
failur
extens
therapeut
applic
bradykinin
potenti
compound
captopril
enalaprilat
ramiprilat
quinaprilat
lisinopril
studi
molecular
action
mechan
becom
increasingli
import
despit
contradictori
degre
confus
find
fortin
regoli
et
al
dendorf
et
al
demonstr
test
system
isol
rabbit
aorta
venoconstrict
potenti
therapeut
use
ace
inhibitor
result
exclu
tabl
select
analogu
bradykinin
potenti
peptid
bpp
distinct
differ
potenti
bradykinin
induc
contract
isol
guinea
pig
ileum
gpi
inhibit
isol
angiotensin
iconvert
enzym
ace
distinct
differ
potenti
bradykinin
induc
contract
guinea
pig
ileum
inhibit
isol
guinea
pig
angiotensini
convert
enzym
disprov
assumpt
potenti
result
exclus
ace
inhibit
quantifi
differ
potenti
inhibit
quotient
calcul
activ
analogu
highest
ace
inhibitori
activ
bpp
quotient
account
compound
show
potenti
compar
bpp
reach
inhibit
ace
analogu
higher
concentr
requir
result
quotient
sive
inhibit
enzymat
bk
degrad
nevertheless
group
regoli
found
influenc
ace
inhibitor
resensit
rabbit
jugular
vein
chang
densiti
b
receptor
rat
spinal
cord
understand
molecular
basi
discrep
mani
approach
undertaken
elucid
influenc
potenti
compound
differ
bradykinin
destroy
enzym
fig
therefor
inhibitor
enzym
also
use
studi
bk
potenti
aminopeptidas
p
inactiv
bk
hydrolyz
arg
pro
bond
inhibitor
enzym
apstatin
potenti
vasodepressor
respons
bk
significantli
reduc
cardiac
ischemia
damag
maggiora
et
al
predict
inhibitor
aminopeptidas
p
exhibit
cardioprotect
effect
potenti
endogen
releas
bk
possibl
act
synergist
ace
inhibitor
regard
direct
interact
potenti
compound
b
receptor
postul
phosphoryl
receptor
ctermin
part
lead
intern
desensit
dephosphoryl
phosphatas
resensit
bradykinin
potenti
factor
influenc
homoand
heterooligomer
b
receptor
includ
interact
receptor
ace
degrad
enzym
fig
recent
spontan
format
b
b
bradykinin
receptor
complex
describ
cell
coexpress
b
b
receptor
receptor
directli
interact
enhanc
signal
enhanc
signal
capac
similar
potenti
hormon
action
thu
find
contain
new
possibl
mechan
potenti
bk
action
bk
potenti
factor
stimul
format
b
b
receptor
complex
also
potenti
action
level
signal
pathway
crosstalk
pathway
induc
hormon
nonreceptor
mediat
intracellular
reaction
observ
studi
influenc
bradykinin
potenti
peptid
bradykinin
b
receptor
cell
transfect
gene
human
receptor
obtain
radioligand
bind
curv
show
differ
displac
presenc
potenti
peptid
thu
potenti
peptid
effect
cell
bind
bradykinin
indic
peptid
use
abl
enhanc
receptor
affin
radioligand
bind
curv
show
influenc
potenti
peptid
receptor
capac
find
clearli
demonstr
analogu
bpp
use
studi
act
alloster
effector
stabil
activ
receptor
conform
induc
homooligomer
receptor
cell
contain
ace
heterodimer
b
receptor
somat
ace
demonstr
marcic
et
al
possibl
system
result
exclud
chang
intern
reintegr
receptor
influenc
potenti
peptid
would
exclud
process
heterodimer
ace
angiotensin
receptor
molecular
level
coimmunoprecipit
ace
b
receptor
antireceptor
antibodi
clearli
indic
interact
partner
cell
membran
contract
smooth
muscl
requir
calcium
ion
consequ
potenti
bkinduc
contract
gpi
depend
extracellular
intracellular
ca
varieti
public
enhanc
intracellular
ca
level
use
qualit
quantit
proof
potenti
action
result
inhibit
ca
uptak
extracellular
sourc
la
indic
potenti
bk
action
requir
mobil
ca
intracellular
store
hand
begin
phase
bkevok
gpi
contract
extracellular
calcium
need
result
la
inhibitor
uptak
ca
extracellular
space
agre
well
find
marcic
et
al
describ
inhibit
resensit
bk
receptor
cho
cell
la
result
clearli
underlin
import
role
extracellular
ca
bkinduc
smooth
muscl
contract
also
evid
mobil
intracellular
ca
necessari
potenti
peptid
bradykinin
induc
format
inositol
phosphat
cell
transient
express
bk
receptor
analogu
potenti
nonapeptid
abl
augment
bk
induc
intracellular
concentr
inositol
phosphat
strike
result
signific
enhanc
basal
level
potenti
peptid
absenc
bradykinin
possibl
indic
nonreceptor
mediat
pathway
bradykinin
trigger
releas
h
label
arachidon
acid
label
phospholipid
presum
activ
phospholipas
g
protein
level
arachidon
acid
significantli
enhanc
bk
transfect
cell
potenti
peptid
slightli
significantli
enhanc
bkmediat
releas
label
arachidon
acid
without
bk
neither
potenti
peptid
signific
influenc
basal
level
contrari
miss
effect
potenti
peptid
bk
induc
enhanc
inositolphosph
releas
arachidon
acid
significantli
increas
molecular
mechan
behind
acceler
remain
unknown
accord
rodrigu
et
al
fernand
et
al
kinin
potenti
peptid
obtain
tryptic
digest
human
serum
protein
involv
ace
inhibit
due
increas
affin
receptor
may
involv
post
receptor
event
link
phospholipas
desensit
resensit
process
receptor
level
elicit
cytosol
receptor
phosphoryl
follow
intern
dephosphoryl
follow
reintegr
cell
membran
fig
dephosphoryl
cytosol
ser
thrand
tyrresidu
bk
receptor
result
activ
protein
phosphatas
calyculin
known
potent
inhibitor
protein
phosphatas
experi
calyculin
influenc
potenti
bkinduc
contract
guinea
pig
ileum
applic
calyculin
neither
bk
administr
chang
potenti
effect
bpp
ramiprilat
smooth
muscl
contractil
contrast
cho
cell
coexpress
b
receptor
ace
human
pulmonari
endotheli
cell
influenc
bradykinin
b
b
receptor
homoand
heterodimer
interact
bradykinin
potenti
peptid
bpp
receptor
subtyp
b
b
angiotensini
convert
enzym
induc
homoor
heterodimer
receptor
complex
format
receptor
membran
bound
enzym
case
amplif
bradykinin
action
expect
format
heterodimer
complex
bkrb
ace
nep
trigger
bpp
describ
literatur
heterodimer
bkrb
bkrb
angiotensinii
receptor
bkrb
detect
without
bpp
homodimer
bkrb
postul
constitut
express
protein
phosphatas
inhibitor
calyculin
block
abil
angiotensin
iconvert
enzym
inhibitor
resensit
receptor
bradykinin
without
alter
primari
effect
bradykinin
believ
differ
result
differ
test
system
time
scale
number
studi
patient
essenti
hypertens
noninsulindepend
diabet
mellitu
indic
minor
improv
glucos
homeostasi
correct
dislipidaemia
indic
bk
enhanc
insulinmedi
glucos
transport
across
cell
membran
therebi
util
glucos
side
insulin
enhanc
bk
respons
rat
skelet
myoblast
neonat
rat
cardiomyocyt
bkinduc
ip
format
enhanc
myoblast
cardiomyocyt
insulin
partial
plc
c
ip
metabol
ip
kinas
ip
promot
ca
mobil
function
ip
inhibit
ip
dephosphoryl
ip
kinas
activ
calmodulindepend
manner
via
insulin
receptor
sinc
intracellular
ca
togeth
calmodulin
involv
regul
insulin
receptor
conform
consequ
activ
effect
lead
autocatalyt
enhanc
ca
signal
ip
stimul
ca
uptak
extracellular
space
ip
mediat
ca
influx
possibl
influenc
ra
shown
fibroblast
ca
uptak
stimul
insulin
crosstalk
two
signal
pathway
tyrosin
kinas
highli
sensit
kinas
inhibitor
genistein
tyrphostin
appear
play
import
role
howev
signal
pathway
bradykinin
b
receptor
insulin
receptor
remain
partial
unclear
figur
give
degre
explan
potenti
action
note
agonist
bk
also
enhanc
activ
bpp
thu
could
show
compar
bk
bpp
abl
enhanc
contract
gpi
induc
angiotensin
ii
eledoisin
histamin
also
potassium
chlorid
result
clearli
indic
unspecif
nonreceptor
bradykinin
bind
receptor
phosphoryl
cytosol
part
intern
dephosphoryl
phosphatas
lead
receptor
reintegr
membran
thu
resensit
assum
bradykinin
potenti
peptid
interact
kinas
phosphatas
inhibit
intern
acceler
resensit
lead
enhanc
receptor
densiti
could
consid
possibl
mechan
potenti
action
figur
potenti
bradykinin
action
insulin
bradykinin
stimul
via
b
receptor
bkrb
gprotein
activ
phospholipas
cb
plc
produc
ip
ip
phosphoryl
kinas
ip
ip
enhanc
cytosol
ca
level
open
ca
influx
channel
promot
ca
releas
sarcoplasmat
reticulum
inhibit
ip
dephosphoryl
thu
lead
autocatalyt
enhanc
ca
signal
increas
cytosol
ca
activ
insulin
receptor
insr
kinas
activ
insulin
receptor
plc
b
activ
bkrb
compet
thu
inhibitor
enhanc
bk
induc
ip
format
presenc
insulin
direct
interact
bradykinin
b
receptor
insulin
receptor
genistein
tyrphostin
sensit
tyrosin
kinas
postul
result
potenti
bradykinin
evok
ip
product
enhanc
insulinmedi
glucos
uptak
insert
transport
membran
mediat
element
potenti
mechan
possibl
direct
gprotein
activ
kind
interact
shown
mast
cell
human
rat
leukemia
cell
line
rat
cerebr
cortic
membran
isol
gprotein
use
differ
peptid
mastoparan
mellitin
substanc
p
adrenocorticotrop
hormon
bradykinin
review
refer
influenc
potenti
factor
migrat
polymorphonuclear
leukocyt
pmn
bk
play
import
role
inflammatori
process
pmn
involv
elucid
action
mechan
potenti
factor
differ
immunocompet
cell
remain
challeng
biologist
immunopharmacologist
bradykinin
stimul
migrat
pmn
correspond
concentr
gradient
fig
effect
character
true
chemotaxi
cell
contain
type
bk
receptor
bkrb
brkb
demonstr
use
bk
agonist
antagonist
migrat
assay
also
contain
complet
system
synthesi
releas
bioactiv
kinin
degrad
bk
proce
pmn
mainli
neutral
endopeptidas
nep
ec
bkinduc
acceler
migrat
pmn
potenti
preincub
min
cell
nep
inhibitor
phosphoramidon
migratori
capac
bk
pmn
also
potenti
ace
inhibitor
ramiprilat
bpp
enhanc
migrat
pmn
induc
well
bk
enzymat
stabl
bk
agonist
darg
hyp
thi
eabu
bphe
bk
unabl
enhanc
migratori
activ
nonpeptid
agonist
bkrb
agonist
desarg
bk
contrast
ignjatov
et
al
found
cell
concentrationdepend
direct
activ
b
receptor
absenc
kinin
activ
potenti
nonapeptid
could
detect
without
administr
b
b
agonist
pmn
cell
though
migratori
activ
proteolyt
stabil
bkanalogu
potenti
action
nonpeptid
agonist
could
acceler
bpp
ramiprilat
difficult
explain
find
agreement
weaker
acceler
stabil
bk
analogu
effect
nep
inhibitor
phosphoramidon
concentrationdepend
potenti
induc
bpp
might
suppos
test
system
potenti
occur
possibl
exclus
inhibit
enzymat
bk
degrad
also
consid
differ
mechan
peptid
nonpeptid
agonist
assumpt
support
test
reduc
intrins
activ
nonpeptid
agonist
compar
bk
although
doserespons
curv
shift
left
potenti
action
despit
mani
long
year
experiment
research
investig
remain
phenomenon
fulli
understood
begin
studi
potenti
smooth
muscl
contract
year
ago
search
extend
organ
vascular
system
differ
bradykinin
degrad
enzym
immunocompet
cell
last
decad
molecular
mechan
level
bradykinin
receptor
signal
pathway
primarili
studi
cell
cultur
potenti
peptid
peptidomimet
besid
oligopeptid
isol
snake
venom
use
studi
broaden
research
field
provid
clear
indic
potenti
bradykinin
action
occur
differ
mechan
depend
system
use
appli
potenti
factor
gener
contradictori
find
therefor
explan
literatur
seem
result
complex
system
also
use
enzymat
fulli
stabl
bradykinin
agonist
speci
depend
bradykinin
receptor
differ
proteas
composit
tissu
cell
line
use
differ
studi
differ
structur
requir
catalyt
center
ace
furthermor
keep
mind
differ
densiti
bk
receptor
local
microdo
main
plasma
membran
presenc
certain
hormon
receptor
differ
signal
pathway
use
tissu
cell
possibl
influenc
receptor
independ
signal
transduct
gprotein
traffick
pattern
cell
activ
regul
gprotein
signal
addit
potenti
effect
differenti
specif
unspecif
consequ
search
potenti
hormon
action
strongli
relat
recent
research
multifunct
signal
protein
opinion
contradictori
explan
regard
mechan
potenti
primarili
result
differ
factor
includ
high
complex
system
involv
kallikreinkinin
reninangiotensin
system
well
vari
vivo
vitro
test
use
furthermor
suggest
exist
differ
potenti
compound
differ
mechan
action
ferreira
la
alv
ew
henriqu
yamafuji
k
taniguchi
sakamoto
e
thiol
enzym
rat
spleen
produc
bradykinin
potenti
peptid
rat
plasma
immunopharmacolog
sakamoto
e
sakao
taniguchi
yamafuji
k
cathepsin
novel
thiol
enzym
produc
kinin
potenti
peptid
compon
protein
rat
plasma
immunopharmacolog
rodrigu
ms
schaffel
r
assreuy
j
compar
studi
mechan
bradykinin
potenti
induc
bradykininpotenti
peptid
enalaprilat
kininpotenti
peptid
eur
j
pharmacol
